RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Francia, Giulio
Item TypeName
Academic Article Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independent.
Academic Article Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts.
Academic Article Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.
Academic Article Label-Free Raman Imaging to Monitor Breast Tumor Signatures.
Academic Article Bromoethylindole (BEI-9) redirects NF-?B signaling induced by camptothecin and TNFa to promote cell death in colon cancer cells.
Academic Article Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors.
Academic Article Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
Academic Article Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
Academic Article Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.
Academic Article Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts.
Academic Article Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines.
Academic Article Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy.
Academic Article Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Concept Platelet-Derived Growth Factor
Concept Tumor Necrosis Factor-alpha
Concept Transforming Growth Factor alpha
Concept Receptors, Growth Factor
Concept Receptor, erbB-2
Concept Receptor Protein-Tyrosine Kinases
Concept Receptors, Vascular Endothelial Growth Factor
Concept Vascular Endothelial Growth Factor Receptor-2
Concept Receptor, Endothelin B
Concept Receptor, Melanocortin, Type 4
Concept Receptor-Interacting Protein Serine-Threonine Kinases
Academic Article Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma.
Academic Article ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth.
Academic Article Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib.
Search Criteria
  • Receptor
  • Platelet Derived Growth Factor
  • alpha
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support